News
SpliceBio has closed a Series B financing round, raising $135m for the clinical development of SB-007 for Stargardt disease.
The campaign ‘Insurance United Against Dementia’ has appointed Marsh McLennan UK CEO, Chris Lay, as its new chairperson.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback